CLIC1 and cancer: Importantly, in endothelial cells [21] and cancer models [51], Clic1 inhibitor, Indanyloxyacetic acid (IAA) has been shown to functionally inhibit Clic1 by preventing translocation to the transmembrane region, and Clic1 remains predominantly in the cytoplasmic compartment [21].